Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth In Vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1002/pros.22963
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2015
- Urheber
-
Kroon, Jan
Buijs, Jeroen T.
Horst, Geertje van der
Cheung, Henry
Mark, Maaike van der
Bloois, Louis van
Rizzo, Larissa Y.
Lammers, Twan
Pelger, Rob C.
Storm, Gert
Pluijm, Gabri van der
Metselaar, Josbert M.
- DOI
-
10.18154/RWTH-2015-02608
- URN
-
urn:nbn:de:101:1-2019062506020073454625
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kroon, Jan
- Buijs, Jeroen T.
- Horst, Geertje van der
- Cheung, Henry
- Mark, Maaike van der
- Bloois, Louis van
- Rizzo, Larissa Y.
- Lammers, Twan
- Pelger, Rob C.
- Storm, Gert
- Pluijm, Gabri van der
- Metselaar, Josbert M.
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2015
Ähnliche Objekte (12)
![Evaluation of the role of PP2Cα [PP2Calpha] in growth regulation, in cellular stress signaling and in tumorigenesis](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Evaluation of the role of PP2Cα [PP2Calpha] in growth regulation, in cellular stress signaling and in tumorigenesis
Nanomedicine Tumor Targeting
Nanomedicine Tumor Targeting
Challenges in nanomedicine clinical translation
Challenges in nanomedicine clinical translation
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Nanomedicine formulations for combination therapies
Nonspherical microbubbles for ultrasound-mediated drug delivery
Bridging the gap between lab and clinic for nanodiagnostics
Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPR
Evaluation of the role of PP2Cα [PP2Calpha] in growth regulation, in cellular stress signaling and in tumorigenesis
Nanomedicine Tumor Targeting
Nanomedicine Tumor Targeting
Challenges in nanomedicine clinical translation
Challenges in nanomedicine clinical translation
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Nanomedicine formulations for combination therapies
Nonspherical microbubbles for ultrasound-mediated drug delivery
Bridging the gap between lab and clinic for nanodiagnostics
Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPR
Evaluation of the role of PP2Cα [PP2Calpha] in growth regulation, in cellular stress signaling and in tumorigenesis
Nanomedicine Tumor Targeting
Nanomedicine Tumor Targeting
Challenges in nanomedicine clinical translation
Challenges in nanomedicine clinical translation
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer
Nanomedicine formulations for combination therapies
Nonspherical microbubbles for ultrasound-mediated drug delivery
Bridging the gap between lab and clinic for nanodiagnostics